A double-blind, placebo-controlled study of HP-5070 in patients with primary hyperhidrosis
Phase 3
- Conditions
- Primary local hyperhidrosis
- Registration Number
- JPRN-jRCT2031200142
- Lead Sponsor
- Customer Service Office
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Japanese patients aged 12 years or older
- Patients with a diagnosis of primary local hyperhidrosis
- Patients with involvement of palmar sites
Exclusion Criteria
- Patients with secondary hyperhidrosis
- Patients with heavy sweating due to climacteric disturbance
- Patients who have undergone surgery for hyperhidrosis (sympathectomy, nerve block, laser surgery, etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of responders with the defined volume of sweat
- Secondary Outcome Measures
Name Time Method HDSS (Hyperhidrosis Disease Severity Scale)<br>DLQI (Dermatology Life Quality Index) score<br>Adverse events